Showing results (1721-1730 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|August 23, 2020
SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2Lisa von Wenserski, Christoph Schultheiß, Sarah Bolz, et al.Leukemia|July 12, 2020
Genome instability in multiple myelomaCarl Jannes Neuse, Oliver C Lomas, Christoph Schliemann, et al.Leukemia|July 12, 2020
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic reviewJie Zhu, Yong Yang, Jin Tao, et al.Leukemia|August 1, 1988
Decreased pathogenicity of murine leukemia virus-Moloney in gnotobiotic miceD D Isaak, K F Bartizal, M J CaulfieldLeukemia|August 9, 2020
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangementsYan Zi Au, Muxin Gu, Etienne De Braekeleer, et al.Leukemia|August 22, 2020
PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndromeKazumasa Aoyama, Daisuke Shinoda, Emi Suzuki, et al.Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.Leukemia|July 8, 2020
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemiaManuel Abecasis, Nicholas C P Cross, Manuel Brito, et al.Leukemia|April 25, 2021
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemiaJulia W Bӧhm, Keith C S Sia, Connor Jones, et al.Leukemia|April 8, 2023
A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responsesFerran Araujo-Ayala, Cèlia Dobaño-López, Juan García Valero, et al.Pageof 963